Goosebumps wrote: -------------------------------
Post# of 148175
(Total Views: 739)
Posted On: 01/31/2021 7:35:44 PM
Re: Goosebumps #75447
Goosebumps wrote:
I guess the big question is and what Dr BP is saying is. We need to meld the diagnostics with the clinical care and this is not currently happening. We have the technology by tests to know where we are at every level of COVID-19 progression. But the problem is we are treating it on a whim with experience and not actual fact of a diagnostic testing. It would appear there is a break down from one advanced science based diagnostic to a clinical experience to treat COVID-19 to the best of what our technology can muster.
Read More: https://investorshangout.com/post/view?id=603...z6lApTsnGe
Dr. BP, Dr Yo, and Dr. Parikh are developing a program for long haulers. See link below for their website.
https://covidlonghaulers.com/
This is from their website:
"Who are we?
Our virtual Chronic COVID Treatment Center is led by the research of virologist and immunologist, Dr. Bruce Patterson, CEO of IncellDX and supported clinically by Drs. Ram Yogendra and Purvi Parikh. Along with our team, we are building a national network of physicians, nurse practitioners and other medical providers to provide a holistic and clinical approach to treatment."
Dr. BP just tweeted this:
It is my understanding they will have a network of doctors and labs using IncellDX assays to develop unique treatment plans to help long haulers based on blood samples drawn by the long hauler's medical provider and sent to one of their labs.
This looks like a good example of blending diagnostics with clinical care.
If there were enough Leronlimab available to cover patients and long haulers, perhaps this would not be necessary. In the meantime, this will hopefully help many long haulers who have been suffering for a long time.
I follow Dr. BP and Dr. Yo on Twitter. There is a very large interest in this program including long haulers in other countries. They do plan to expand overseas.
I guess the big question is and what Dr BP is saying is. We need to meld the diagnostics with the clinical care and this is not currently happening. We have the technology by tests to know where we are at every level of COVID-19 progression. But the problem is we are treating it on a whim with experience and not actual fact of a diagnostic testing. It would appear there is a break down from one advanced science based diagnostic to a clinical experience to treat COVID-19 to the best of what our technology can muster.
Read More: https://investorshangout.com/post/view?id=603...z6lApTsnGe
Dr. BP, Dr Yo, and Dr. Parikh are developing a program for long haulers. See link below for their website.
https://covidlonghaulers.com/
This is from their website:
"Who are we?
Our virtual Chronic COVID Treatment Center is led by the research of virologist and immunologist, Dr. Bruce Patterson, CEO of IncellDX and supported clinically by Drs. Ram Yogendra and Purvi Parikh. Along with our team, we are building a national network of physicians, nurse practitioners and other medical providers to provide a holistic and clinical approach to treatment."
Dr. BP just tweeted this:
It is my understanding they will have a network of doctors and labs using IncellDX assays to develop unique treatment plans to help long haulers based on blood samples drawn by the long hauler's medical provider and sent to one of their labs.
This looks like a good example of blending diagnostics with clinical care.
If there were enough Leronlimab available to cover patients and long haulers, perhaps this would not be necessary. In the meantime, this will hopefully help many long haulers who have been suffering for a long time.
I follow Dr. BP and Dr. Yo on Twitter. There is a very large interest in this program including long haulers in other countries. They do plan to expand overseas.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼